Bristol-Myers, Natco And More Can't Ditch Cancer Drug MDL
By Hailey Konnath · September 30, 2026, 12:04 AM EDT
A New Jersey federal judge Tuesday refused to throw out sprawling antitrust multidistrict litigation over Celgene Corp.'s cancer drug Revlimid filed against Bristol-Myers Squibb, Natco Pharma, AbbVie and other pharmaceutical companies,...
To view the full article, register now.